Dr Pak has demonstrated a significant leadership in promoting EBP teaching in complementary medicine industry which is confronted with the lack of evidence. When he continues to present the underlying mechanism for treatment through publications, there is potential to: (a) facilitate consistency of patient care across professional boundaries and (b) empower patients to manage their own health care.

Over the years, his principal focus has been on the experimental/clinical application of bee venom to human diseases. The following are two examples of where his research related to bee venom has been acknowledged: (a) His research has been recognised by an invitation from the publishing company Springer to write two chapters on ‘Chemical Composition of Bee Venom’ and ‘Health Benefits and Uses in Medicine of Bee Venom’ for the publication of a book entitled “Bee products - chemical and biological properties”. This invitation is directly related to his research on honeybee venom, focusing on health benefits and uses in medicine. (b) He was appointed as the Guest Editor of a Special Issue on “Bee and wasp venoms: biological characteristics and therapeutic application” for the journal TOXINS (ISSN 2072-6651). He currently leads and guides research into nutraceuticals to provide relevant and impactful clinical applications.